MAPT and Alzheimer disease: While we observed this relationship in CU, the pTau217 levels in CI were, in contrast, more related to aggregated tau (r = 0.8) than to Aβ (r = 0.6) pathology on PET to the point that it enabled staging of AD based on brain tau levels.